மானிங் குடும்பம் அடித்தளம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மானிங் குடும்பம் அடித்தளம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மானிங் குடும்பம் அடித்தளம் Today - Breaking & Trending Today

Atsena Therapeutics Raises $55M in Series A Financing


Atsena Therapeutics, a Durham, N.C. and Boston, MA-based clinical-stage gene therapy company, closed a $55m Series A financing.
The round was led by Sofinnova Investments with participation from additional new investors Abingworth and Lightstone Ventures and founding investors Hatteras Venture Partners and the Foundation Fighting Blindness’ RD Fund, and existing investors Osage University Partners, University of Florida, and Manning Family Foundation. In conjunction with the funding, Sarah Bhagat, PhD, Partner at Sofinnova, Jackie Grant, PhD, Principal at Abingworth, and Jason Lettmann, General Partner at Lightstone, will join Atsena’s board of directors.
The company intends to use the funds to: ....

United States , Jackie Grant , Shannon Boye , Sanford Boye , Jason Lettmann , Patrick Ritschel , Sarah Bhagat , Manning Family Foundation , University Of Florida , Osage University Partners , Foundation Fighting Blindnes Rd Fund , Atsena Therapeutics , Sofinnova Investments , Lightstone Ventures , Hatteras Venture Partners , Foundation Fighting Blindnes , Manning Family , General Partner , Chief Executive Officer , ஒன்றுபட்டது மாநிலங்களில் , ஜாக்கி மானியம் , ஶ்யாநந் பாய் , சான்ஃபோர்ட் பாய் , சாரா பகத் , மானிங் குடும்பம் அடித்தளம் , பல்கலைக்கழகம் ஆஃப் புளோரிடா ,

Atsena Therapeutics Raises $55 Million Series A Financing to Advance LCA1 Gene Therapy Clinical ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Atsena Therapeutics Raises $55 Million Series A Financing to Advance LCA1 Gene Therapy Clinical .
Atsena TherapeuticsDecember 16, 2020 GMT
Round was led by Sofinnova Investments with participation from Abingworth, Lightstone Ventures and all existing investors
Company expands board of directors and plans to build out team
DURHAM, N.C. and BOSTON, Dec. 16, 2020 (GLOBE NEWSWIRE) Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced it has closed an oversubscribed $55 million Series A financing led by Sofinnova Investments with participation from additional new investors Abingworth and Lightstone Ventures. Founding investors Hatteras Venture Partners and the Foundation Fighting Blindness’ RD Fund, along with existing investors Osage University Partner ....

United States , North Carolina , City Of , United Kingdom , Jackie Grant , Shannon Boye , Jason Lettmann , Sanford Boye , Tony Plohoros , Patrick Ritschel , Sarah Bhagat , Manning Family Foundation , University Of Florida , Osage University Partners , Foundation Fighting Blindnes Rd Fund , Carolina Research Triangle , Sofinnova Investments , Lightstone Ventures , Hatteras Venture Partners , Foundation Fighting Blindnes , General Partner , Chief Executive Officer , Research Triangle , Menlo Park , Claret Medical , ஒன்றுபட்டது மாநிலங்களில் ,

Eyeing phase 3, Atsena raises $55M financing for blindness gene therapy


(YaroslavKryuchka/Getty Images)
University of Florida (UF) spinout Atsena Therapeutics has closed a $55 million financing that will help take its gene therapy for a common cause of blindness in children into pivotal trials.
The gene therapy is already in a phase 1/2 trial for Leber congenital amaurosis (LCA) a disease that progressively destroys the retina in patients with a mutation in the GUCY2D gene. Atsena acquired the candidate from Sanofi earlier this year, which in turn licensed it from UF.
The Durham, North Carolina-based biotech is hoping to follow in the footsteps of Spark Therapeutics (now part of Roche), whose Luxturna became the first directly administered gene therapy to be approved in the U.S. in 2017. ....

United States , North Carolina , Pat Ritschel , Shannon Boye , Lightstone Jason Lettmann , Sanford Boye , Sarah Bhagat , Manning Family Foundation , Uf College Of Medicine , University Of Florida , Osage University Partners , Foundation Fighting Blindness , Carolina Research Triangle , Atsena Therapeutics , North Carolina Based , Spark Therapeutics , Unified Clinical Data Capture , Chief Scientific Officer Shannon Boye , Chief Technology Officer Sanford Boye , Research Triangle , Hatteras Venture Partners , Sofinnova Investments , Jackie Grant , ஒன்றுபட்டது மாநிலங்களில் , வடக்கு கரோலினா , ஶ்யாநந் பாய் ,